Zentalis Pharmaceuticals to participate in Guggenheim and Stifel healthcare conferences

ZNTL•2026-11-03

Zentalis Pharmaceuticals management will join a fireside discussion at the Guggenheim 3rd Annual Healthcare Innovation Conference on November 10, 2026, and present at the Stifel 2026 Healthcare Conference on November 11.

1. Conference schedule

Zentalis management is scheduled to join a fireside discussion at the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on November 10, 2026, at 2 p.m. ET. A company presentation at the Stifel 2026 Healthcare Conference in New York is scheduled for November 11 at 4 p.m. ET.

Zentalis Pharmaceuticals to participate in Guggenheim and Stifel healthcare conferences

1. Conference schedule

Related News

Q2 Holdings grants Co-CEO Jonathan Price 44,268 restricted stock units

Global Water Resources Q3 2026 net income drops 42% to $1 million; revenue rises 5% to $16.3 million

Suncor Energy Q3 adjusted operating earnings CAD 4,631 million

Suncor Q3 2026 adjusted operating earnings more than double year over year to Cdn$4.63 billion

PubMatic Chief Accounting Officer Lisa Gimbel reports sale of common shares worth $8,065